| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.25043 |
| P698 | PubMed publication ID | 20039421 |
| P2093 | author name string | E Lubberts | |
| M van Driel | |||
| J M W Hazes | |||
| J P T M van Leeuwen | |||
| A M C Mus | |||
| E M Colin | |||
| J P van Hamburg | |||
| P S Asmawidjaja | |||
| P2860 | cites work | Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol | Q42505016 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| interleukins | Q194908 | ||
| P304 | page(s) | 132-142 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis | |
| P478 | volume | 62 |
| Q36029113 | 1,25(OH)2D3 Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept |
| Q58711835 | 1,25(OH)D and dexamethasone additively suppress synovial fibroblast activation by CCR6 T helper memory cells and enhance the effect of tumor necrosis factor alpha blockade |
| Q64241054 | 1,25-Dihydroxyvitamin D3 Ameliorates Collagen-Induced Arthritis via Suppression of Th17 Cells Through miR-124 Mediated Inhibition of IL-6 Signaling |
| Q35192119 | 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. |
| Q47171590 | 1,25-dihydroxyvitamin D3 reduces mouse airway inflammation of neutrophilic asthma by transcriptional modulation of interleukin-17A. |
| Q34848695 | A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease |
| Q36494694 | Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses |
| Q47108321 | Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. |
| Q35201856 | Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer |
| Q92862429 | Artocarpus tonkinensis Protects Mice Against Collagen-Induced Arthritis and Decreases Th17 Cell Function |
| Q37564678 | Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults |
| Q36418390 | Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses |
| Q35067840 | B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls |
| Q37866633 | Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. |
| Q37497197 | Both immune hormone IL-10 and parathormone tend to increase in serum of old osteoporotic people independently of 1, 25 dihydroxy vitamin D3 |
| Q38704121 | Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature |
| Q42988617 | Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? |
| Q42070930 | Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy |
| Q51165596 | Comparison of plasma vitamin D levels in patients with Sjögren's syndrome and healthy subjects. |
| Q35114894 | Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling |
| Q39181014 | Current perspectives on the role of IL-17 in autoimmune disease |
| Q34664175 | Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease |
| Q40589431 | Diminished IL-17A levels may protect filarial-infected individuals from development of rheumatoid arthritis and systemic lupus erythematosus. |
| Q51598621 | Dll4 in the DCs isolated from OVA-sensitized mice is involved in Th17 differentiation inhibition by 1,25-dihydroxyvitamin D3 in vitro. |
| Q41845753 | ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints |
| Q37516324 | Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D |
| Q38066985 | Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review |
| Q37361364 | Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17/Th1 cell in patients with acute coronary syndrome |
| Q58108351 | Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis |
| Q44781663 | Frequencies of circulating IL-17-producing CD4+CD161+ T cells and CD4+CD161+ T cells correlate with disease activity in rheumatoid arthritis |
| Q50316889 | From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis? |
| Q51415619 | Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis. |
| Q92404720 | Human Memory Th17 Cell Populations Change Into Anti-inflammatory Cells With Regulatory Capacity Upon Exposure to Active Vitamin D |
| Q37371889 | Hypovitaminosis D and Cervical Disk Herniation among Adults Undergoing Spine Surgery |
| Q52643628 | IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. |
| Q35447373 | Immunomodulation by vitamin D: implications for TB. |
| Q61455241 | Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus-A Narrative Review |
| Q38557312 | Immunomodulatory mechanisms of action of calcitriol in psoriasis |
| Q33908937 | Immunopathogenesis of ocular Behçet's disease |
| Q49825617 | Impact of vitamin D deficiency on clinical parameters in treatment-naïve rheumatoid arthritis patients |
| Q45365271 | Increased aryl hydrocarbon receptor expression in patients with allergic rhinitis |
| Q44466098 | Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis |
| Q34634513 | Increased expression of IL-22 is associated with disease activity in Behcet's disease |
| Q34224709 | Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis |
| Q35617683 | Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy |
| Q50517496 | Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. |
| Q38284573 | Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy |
| Q41201554 | Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells |
| Q57074018 | Losartan, but not Enalapril and Valsartan, Inhibits the Expression of IFN-γ, IL-6, IL-17F and IL-22 in PBMCs from Rheumatoid Arthritis Patients |
| Q53148065 | Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice. |
| Q39490304 | Low socio-economic status is a newly identified independent risk factor for poor vitamin D status in severely obese adults |
| Q51145037 | Low vitamin D level is not associated with increased incidence of rheumatoid arthritis. |
| Q26781318 | Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D |
| Q27023996 | Mechanisms underlying effects of 1,25-Dihydroxyvitamin D3 on the Th17 cells |
| Q37375129 | Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. |
| Q27026399 | New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases |
| Q50571596 | No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study. |
| Q42927179 | Paricalcitol, a synthetic vitamin D analog: A candidate for combination therapy with biological agents in rheumatoid arthritis |
| Q90462302 | Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases |
| Q36317874 | Performance evaluation of FlowCytomix assays to quantify cytokines in patients with rheumatoid arthritis |
| Q42370171 | Periodontal disease, Porphyromonas gingivalis, and rheumatoid arthritis: what triggers autoimmunity and clinical disease? |
| Q33768232 | Psychoneuroimmunoendocrinology: clinical implications |
| Q38164438 | Re-evaluating the role of vitamin D in the periodontium |
| Q51082282 | Relation between bone mineral density and IL-17 serum levels in Serbian patients with early Rheumatoid arthritis. |
| Q34346316 | Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression |
| Q37987880 | Role of IL-17 in psoriasis and psoriatic arthritis |
| Q88924562 | Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies |
| Q36157081 | Sequence analysis of four vitamin D family genes (VDR, CYP24A1, CYP27B1 and CYP2R1) in Vogt-Koyanagi-Harada (VKH) patients: identification of a potentially pathogenic variant in CYP2R1 |
| Q62733704 | Serum and synovial fluid vitamin D metabolites and rheumatoid arthritis |
| Q38425628 | Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis |
| Q59313325 | Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis |
| Q37932438 | T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)₂ vitamin D. |
| Q84983013 | Th17 cells and human arthritic diseases |
| Q54406138 | Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin‐17A production |
| Q37686348 | Th17 cytokines and arthritis |
| Q38439641 | The IL-23-IL-17 axis in inflammatory arthritis |
| Q58789362 | The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus |
| Q39186373 | The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases |
| Q39146450 | The contrasting roles of Th17 immunity in human health and disease |
| Q30252056 | The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis |
| Q42079187 | The effects of 1,25-dihydroxyvitamin D3 on in vitro human NK cell development from hematopoietic stem cells. |
| Q35743863 | The microbiome and rheumatoid arthritis |
| Q38050401 | The multiple facets of glucocorticoid action in rheumatoid arthritis |
| Q28577203 | The vitamin D receptor regulates rheumatoid arthritis synovial fibroblast invasion and morphology |
| Q34375258 | Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis |
| Q37981255 | Translating the role of vitamin D3 in infectious diseases |
| Q54649429 | Upregulation of interleukin-1β production by 1,25-Dihydroxyvitamin D3 in activated human macrophages |
| Q38916397 | Vitamin D Deficiency and Rheumatoid Arthritis. |
| Q37307601 | Vitamin D Supplementation for Patients with Dry Eye Syndrome Refractory to Conventional Treatment. |
| Q60916990 | Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough |
| Q35586041 | Vitamin D and 1,25(OH)2D regulation of T cells |
| Q98165195 | Vitamin D and early rheumatoid arthritis |
| Q37919185 | Vitamin D and immune function: an overview |
| Q92798751 | Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response |
| Q57821076 | Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapy |
| Q35174915 | Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis |
| Q50653450 | Vitamin D improves cognitive function and modulates Th17/T reg cell balance after hepatectomy in mice. |
| Q34550631 | Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. |
| Q33833563 | Vitamin D in inflammatory diseases |
| Q38611147 | Vitamin D in rheumatoid arthritis-towards clinical application |
| Q88186209 | Vitamin D levels and bone mass in rheumatoid arthritis |
| Q54940611 | Vitamin D levels correlate with lymphocyte subsets in elderly patients with age-related diseases. |
| Q38206253 | Vitamin D receptor agonists' anti-inflammatory properties |
| Q26849424 | Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathy |
| Q55354028 | Vitamin D status and its influence on outcomes following major burn injury and critical illness. |
| Q26865776 | Vitamin D, multiple sclerosis and inflammatory bowel disease |
| Q42219099 | Vitamin D, steroid hormones, and autoimmunity |
| Q38368241 | Vitamin D: Immuno-modulation and tuberculosis treatment |
| Q58614683 | Vitamin D: Nutrient, Hormone, and Immunomodulator |
| Q30375070 | Vitamin D—update for the pediatric rheumatologists |
| Q48162662 | Wellness and the Role of Comorbidities in Multiple Sclerosis. |
Search more.